|1.||Naranmandura, Hua: 4 articles (09/2011 - 04/2007)|
|2.||Suzuki, Kazuo T: 3 articles (03/2008 - 04/2007)|
|3.||Del Razo, Luz M: 2 articles (11/2011 - 03/2005)|
|4.||Valenzuela, Olga L: 2 articles (11/2011 - 03/2005)|
|5.||Cohen, Samuel M: 1 article (10/2013)|
|6.||Arnold, Lora L: 1 article (10/2013)|
|7.||Liu, Xiangde: 1 article (10/2013)|
|8.||Qiu, Fang: 1 article (10/2013)|
|9.||Rennard, Stephen I: 1 article (10/2013)|
|10.||Kakiuchi-Kiyota, Satoko: 1 article (10/2013)|
11/01/2011 - "Metabolic conversions of iAs that yield highly toxic and genotoxic methylarsonite (MAsIII) and dimethylarsinite (DMAsIII) may play a significant role in determining the extent and character of toxic and cancer-promoting effects of iAs exposure. "
03/01/2005 - "Metabolic conversions of iAs that yield highly toxic and genotoxic methylarsonite (MAsIII) and dimethylarsinite (DMAsIII) may play a significant role in determining the extent and character of toxic and cancer-promoting effects of iAs exposure. "
10/04/2013 - "In this study, cytotoxicity and gene expression changes for arsenite (iAs(III)), monomethylarsonous acid (MMA(III)) and dimethylarsinous acid (DMA(III)) were evaluated in three human cell types, urothelial (1T1), keratinocyte (HEK001) and bronchial epithelial (HBE) cells, corresponding to target organs for iAs-induced cancer. "
03/27/2013 - "Inorganic arsenic [As(V)+As(III)] and its metabolites, especially the trivalent forms [monomethylarsonous acid, MMA(III), and dimethylarsinous acid, DMA(III)], are considered the forms of arsenic with the highest degree of toxicity, linked to certain types of cancer and other pathologies. "
03/15/2008 - "Thioarsenicals dimethylmonothioarsinic (DMMTA(V)) and dimethyldithioarsinic (DMDTA(V)) acids are common urinary metabolites, the former being much more toxic than non-thiolated dimethylarsinic acid (DMA(V)) and comparable to dimethylarsinous acid (DMAIII) in epidermoid cells, suggesting that the metabolic production of thioarsenicals may be a risk factor for the development of cancer in these organs. "
|2.||Hepatocellular Carcinoma (Hepatoma)
09/01/2005 - "In the present study, we investigated cyto-/genotoxic effects of the arsenic compounds arsenate [As(i)(V)], arsenite [As(i)(III)], monomethylarsonic acid [MMA(V)], monomethylarsonous acid [MMA(III)], dimethylarsinic acid [DMA(V)], dimethylarsinous acid [DMA(III)], and trimethylarsine oxide [TMAO(V)] after an extended exposure time (24 h) and compared the uptake capabilities of fibroblasts (CHO-9 cells: Chinese hamster ovary) used for genotoxicity studies, with those of hepatic cells (Hep G2: hepatoma cell-line). "
|3.||Urinary Bladder Neoplasms (Bladder Cancer)
09/19/2011 - "The present study was performed to gain insight into the toxicity and accumulation of arsenic species found in urine, including arsenate (iAs(V)), arsenite (iAs(III)), monomethylarsonic acid (MMA(V)), monomethylmonothioarsonic acid (MMMTA(V)), dimethylarsinic acid (DMA(V)), dimethylarsinous acid (DMA(III)), dimethylmonothioarsinic acid, (DMMTA(V)), and dimethyldithioarsinic acid (DMDTA(V)) in human bladder cancer EJ-1 cells. "
02/15/2013 - "We have previously shown that micromolar concentrations of arsenite (iAs(III)) or its methylated trivalent metabolites, methylarsonite (MAs(III)) and dimethylarsinite (DMAs(III)), inhibit the insulin-activated signal transduction pathway, resulting in insulin resistance in adipocytes. "
|2.||Cacodylic Acid (Cacodylate)
|4.||arsenic acid (arsenate)
|5.||monomethylarsonic acid (MSMA)
|7.||Arsenicals (Arsenic Compounds)